• 1
    Leppik IE. Intractable epilepsy in adults. Epilepsy Res 1992;(suppl 5):711.
  • 2
    Salazar AM, Jabbari B, Vance SC, et al. Epilepsy after penetrating head injury, I: clinical correlates: a report of the Vietnam Head Injury Study. Neurology 1985;35: 140614.
  • 3
    Marks DA, Kim J, Spencer DD, et al. Characteristics of intractable seizures following meningitis and encephalitis. Neurology 1992;42: 15138.
  • 4
    Marks DA, Kim J, Spencer DD, et al. Seizure localization and pathology following head injury in-patients with uncontrolled epilepsy. Neurology 1995;45: 20517.
  • 5
    Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001;42: 51524.
  • 6
    Jacobs MP, Fischbach GD, Davis MR, et al. Future directions for epilepsy research. Neurology 2001;57: 153642.
  • 7
    Löscher W. Animal models of epilepsy and epileptic seizures. In: EadieMI, VajdaRJE, eds. Handbook of experimental pharmacology. Vol. 138 Antiepileptic drugs: pharmacology and therapeutics. Berlin: Springer Verlag, 1999: 1962.
  • 8
    Avanzini G, Moshé SL, Schwartzkroin PA, et al. Animal models of localization-related epilepsy. In: EngelJJr, PedleyTA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997: 42742.
  • 9
    Stables James P, Kupferberg HJ. The NIH Anticonvulsant Drug Development (ADD) Program: Preclinical Anticonvulsant Screening Project. In: AvanziniG, TanganelliP, AvoliM, eds. Molecular and cellular targets for antiepileptic drugs. London: John Libbey, 1997: 1918.